Background: to describe population patterns of influenza vaccination, and to analyse the effect of a set of demographic, socio-economic status, lifestyles, health status, and health services variables, on the likelihood of being vaccinated in the those ≥65 years. Methods: Cross-sectional study. From the 1997 National Health Survey those ≥65 years old were selected. Adjusted odds ratios were calculated through multiple logistic regression models, reporting having an influenza vaccination last season as a dependent variable. Results: A total sample of 1148 was analysed: 51.3% of subjects reported having received a vaccination last year. Adjusted odds ratios showed that the risk of not having been vaccinated was higher for people from 65-69 years Factors that have been identified as barriers to receiving this effective intervention are: younger age, female sex, less contact with the health care system, smokers, and not having high-risk chronic conditions. No effect was found for socio-economic status or variables related with health, functional status or other health-related behaviours. This study may contribute to identifying population groups who could be targeted for health promotion interventions aimed to improve their influenza vaccination uptake.
Inf luenza claims tens of thousands of lives each year.
Annual influenza vaccination is recommended for persons at increased risk of complications from influenza, including all adults aged ≥65 years and younger adults with some chronic conditions. Influenza vaccine is an effective intervention to prevent the disease and its complications: exacerbation of pre-existing medical conditions, secondary bacterial pneumonia, and primary influenza viral pneumonia. In healthy people, influenza vaccine has been estimated to confer a protection of 65-85%. In chronic patients and people ≥65 years its effectiveness is lower, between 30 and 40%, but it could prevent the more severe consequences of the disease. Influenza vaccine could avoid 50-60% of hospitalizations in this group and about 80% of deaths. Nowadays, most countries have national guidelines for influenza, pneumococcal and tetanus vaccination of highrisk patients. However, and in spite of much progress, the full benefits of these interventions have yet to be achieved in most countries. 1, 2 Different levels of vaccine use have been found, and it has been hypothesized that its use could reflect different levels of awareness of influenza as an important disease and the effectiveness of vaccination in its prevention. In the USA, among adults aged ≥65 years in 1995, 58% reported receiving an influenza vaccination during the previous 12 months. 3 In Italy, vaccination coverage against influenza has been considered quite inadequate, ranging from 26 to 49%. 4 In England, vaccination levels in community dwellings have been found to range between 44 and 59%. 5 In Spain, influenza vaccination is included in the Catalogue de Health Benefits of the National Health System, in Primary Care. The National Health Institute Primary Care General Sub-Directorate has reported that coverage of this services in people ≥65 year old was 57.9% in 1997 and 58.5% in 1998. The National Programme of Prevention Activities of the Spanish Society of Community and Family Medicine reported a coverage of 41. 1%, 52.6%, 47.9% and 48.6% in 1993, 1995, 1997 and 1999, respectively . Different studies have reported vaccination levels ranging between 35 and 65%, 6 60 and 84%, 7 and 65 and 94%. 8 Although vaccination levels are high in Spain, two facts have to be emphasized: the level of vaccination among risk groups could be improved, and significant differences across areas and population groups have been identified. The Spanish National Health System, which guarantees free access at the point of service, was supposed to eliminate differences in access to effective health care. Nevertheless, significant disparities in preventive care utilization persist despite universal and comprehensive insurance coverage. The objective of this work is to describe population patterns of the use of influenza EUROPEAN JOURNAL OF PUBLIC HEALTH 2003; 13: 133-137 vaccination, and to analyse the effect of a set of demographic, socio-economic status, lifestyles, health status, and health services utilization variables, on the likelihood of being vaccinated in the age group ≥65 years.
METHODS
This is a cross-sectional study. The data in this report was gathered from the Spanish National Health Survey from 1997 (ENS-97). The Spanish National Health Department conducts routinely health surveys, using representative samples from the non-institutionalized population. ENS-97 consisted of a multistage probability sample composed of 6396 people 16 years and older. Participants were interviewed in four waves: 18 February-17 March, 19 May-15 June, 15 September-12 October, and 24 November-21 December. Information was requested on perceived morbidity and health, health services and preventive services, lifestyles and socio-demographic characteristics. From this sample, those ≥65 years old were selected. Response to the following question was analysed: 'We would like to know whether you have had a flu vaccine during the last influenza season'. The prevalence of influenza vaccination among adults aged ≥65 years was estimated. For this group, overall vaccination prevalence estimates were presented by age, sex, size of place of residence, education level, family income, smoking habit, self-reported health, chronic disease, public and/or private health insurance, and time since last visit to a doctor. Then, the independent association of those variables with the preventive procedure was examined using logistic regression. The adjusted odds ratio (OR) of having been vaccinated last year was compared across the different values of the variables described earlier. To evaluate potential differences by age and sex, multiple logistic regression models were computed separately for two age groups, from 65 to 69 and ≥70, and for sex categories, including the variables from the main model. The model fit was assessed by the Hosmer-Lemeshow statistic. SPSS 10.0 was used for all data analysis. Table 1 shows certain sample characteristics. A total sample of 1148 was categorized in this high risk group for influenza-related complications. Prevalence of influenza vaccination is represented by different variables. The mean age was 72.9 (SD 6.1). Overall prevalence of reporting having received influenza vaccine last season was estimated to be 51.3%. Table 2 presents the results of the logistic regression analysis in which all the variables that appeared to be significant in the multiple model were included. In this age group vaccination levels were negatively associated with female sex, younger age, smoking habit, living in >1,000,000 inhabitants cities, more than 2 weeks since last visit to a doctor, and not having a chronic condition which is an indication of influenza vaccination. Table 3 shows the results of the analysis stratified by sex. The effect of age on the risk of not receiving the vaccine was specially relevant for men. Smoking was associated with a lower likelihood of receiving the vaccine also only in men. Having more than 2 weeks since the last contact with a physician had a statistically significant impact only in the case of women. Table 4 displays the stratified analysis by age. No significant differences were found between men and women in the 65-69 age group. Differences between men and women occurred in the group ≥70 years. In the younger group, an increased risk of not having been vaccinated was observed for people living in a city with >1 million inhabitants as well as for smokers and for those with a high-risk chronic condition. Having more than 6 months since the last contact with a physician was significant both for those aged 65-69 years and those ≥70 years, but the effect was particularly high in the latter. The effect that other variables could have on the main model, such as body mass index, physical exercise, selfperceived health, marital status, or functional status, was further explored. None of those variables, however, had a significant association with having being vaccinated nor did any one substantially modify the estimators of the main model.
RESULTS

DISCUSSION
On the basis of the ENS-97, the prevalence of people aged ≥65 years to report receipt of influenza vaccine during the last season was 51.3%. Although Spanish health authorities have not determined a specific target for influenza vaccination, this level can be considered suboptimal. For instance, the United States Healthy People 2010 objective is to increase the proportion of adults who receive influenza vaccination to at least 60%. 3 In Canada, the National Advisory Committee on Immunization has set a 90% target vaccination rate for people aged 65 years or older or at high risk of influenza-related complications. 3 The results from this work have also identified several population groups who are significantly at risk of not receiving this vaccine: women, younger people, residents in large cities, smokers, those with less frequent contact with physicians or who are not suffering from high-risk chronic conditions. No differences were found, however, by educational level or income categories, marital status, availability of private scheme health insurance, self-perceived health, functional status, body mass index, or physical exercise.
Childhood vaccination programmes have achieved extraordinary results in decreasing morbidity and mortality associated with vaccine-preventable diseases in this age group, accomplishing the almost complete eradication of diseases like measles or poliomyelitis. The same success could be obtained for the population ≥65 years regarding some vaccine-preventable diseases, like tetanus, pneumococcal-related diseases or influenza and its complications. In order to succeed in this effort, identifying barriers to immunization is an important first step. Recent studies have analysed influenza vaccination levels in other countries, but nationally representative data from Spain was not available. This work expands results from earlier studies in Spain, adding to the previous work information from a national population based sample and 
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identifying variables associated with lack of utilization of this effective preventive intervention. Some limitations of these findings have to be mentioned. The most important being that the data analysed was self-reported information about influenza vaccination. However, in previous studies, although not assessed in Spain, self-report of influenza vaccination has been shown to be a highly sensitive (0.98) and a moderately specific measure (0.71). 9 As influenza vaccination is usually administered in October and November, prior to the onset of winter, questions on physician contact could be biased if recent contact is not related to the period when vaccination normally takes place. ENS-97 was representative only of the non-institutionalized population, and levels of vaccination in community-dwelling old people could be different from that for institutionalised persons. Also, ENS-97 did not include information regarding other chronic diseases, also an indication of influenza vaccination, such as chronic kidney disease, tuberculosis, current treatment for cancer, liver disease or cirrhosis, anaemia or immune-deficiency. Another issue that should be mentioned is the cross-sectional nature of the survey used as information source. It could not be ascertained whether people not vaccinated have been offered vaccination and refused or not offered at all. All these factors indicate that we should be cautious about the interpretation of the estimates. Regarding the variables that were found to be significant some comments should be made. Our study showed that women had a lower vaccination level than men. Results from this study also suggest that vaccination rates increase with age, being lower for those less than 70 years. 12 Women tend to have lower vaccination rates, but female vaccination likelihood decreases with age, while the association of age is the reverse among men. The lower level of vaccination in the youngest group has previously been identified. 10 We have found an indirect association between size of place of residence and vaccination levels. People living in cities with more than 1 million inhabitants have a lower likelihood of being vaccinated. This effect, though, was specially relevant for men and for people less than 70 years old. Higher rates of vaccination among rural residents than among urban residents have also been found previously. 11 Smoking was also found to be associated with a lower probability of being vaccinated. This effect was applicable only to men and for those 65-79 years old. Other studies have reported this result. 5 Having a chronic disease is also associated with a higher prevalence of influenza vaccination. This association, though, is not found for the group 65-69 years old. Other studies have also found an association between good health and lower influenza vaccination compliance. 12 Use of physician services has also been found to be another leading determinant of influenza vaccination: the shorter the time period since the last consultation with a doctor, the higher the likelihood of vaccination. 5 However, the decrease in vaccination associated with a longer period without physician contact was found only for women. When assessing the effect of consultation with a doctor on vaccination levels by age levels, the rates of vaccination were statistically significantly lower for those with more than 6 months since their last visit in both groups considered. Inclusion of this variable was considered important, as it allows the control of several factors linked to both current objective health and to symptoms and ailments. Provider recommendation and endorsement of influenza vaccination has a significant reinforcing effect on improving immunization rates, and, therefore, in decreasing the morbidity and mortality associated with influenza. 13 Different approaches have shown how effective and successful are interventions aimed to increase influenza immunization impacting upon physician practice patterns. Some interventions have linked reimbursement with performance, 14, 15 others, just by planning, implementing and documenting health care quality improvement programmes. 16, 17 Our study has demonstrated that although differences in influenza vaccine exist in Spain there is an absence of differences by educational level and family income. Those results are similar to results from previous research which have identified barriers limiting equitable access to health care services, although no differences by socio-economic status were found both for doctor consultation and for hospitalizations. 18 Neither did we find an association between the availability of private health insurance and influenza vaccination in Spain. Previous studies have not found an association between heath care utilization and double insurance coverage. 19 Although influenza vaccination is believed to confer protection, the decision whether or not to accept the vaccine is coloured by many factors. Predictors of acceptance of influenza vaccinations are related with perceived barriers, benefits and severity. Some of the reasons that have been identified for non-vaccination are lack of faith in the vaccine, disbelief that influenza is a dangerous illness, 4 fear of the side-effects of influenza vaccination and perceived good health, 21 lack of necessity of the vaccine, ignorance of the campaign, forgetting, 23 a feeling that the shot is not effective, lack of satisfactory organization to provide immunization, or having received controversial information through the mass media. Most people who have been vaccinated repeat the procedure in following years, although satisfaction with the procedure is also variable. The highest degree of in-satisfaction is shown among women, patients with more visits, and those receiving the vaccine for the first time. Modifiable factors that predict immunization are self-identification as high-risk, belief that the immunization will not cause discomfort, intention to be immunized, and physician recommendation. 25 The need for comprehensive campaigns promoting influenza and other vaccines, like the pneumococcal vaccine, should be highlighted. 26 Sound evidence suggests that further progress in increasing adult immunization coverage is possible. 33 Systematic information and education programmes, mailing brochures or invitations, targeted at the elderly have shown to be effective interventions in increasing influenza vaccination rates. 27-32 Increasing knowledge and attitudes of patients through provider recommendations, as well as peer-to-peer programmes, also enhance vaccination rates. 34, 35 Health promotion activities regarding influenza immunization should be specifically directed to increasing awareness of those who belong to high-risk groups, developing proactive systems emphasizing providers' recommendations and patient reminders. Individualized and ongoing education and information by the primary healthcare team is fundamental. 23 Also, patients' concerns regarding immunization 24 that impede acceptance of the vaccines should be addressed. 22 Cultural or regional differences in attitudes towards influenza and vaccination should be taken into account when designing those campaigns. This study has enabled the identification of different population groups with a significant higher risk of not receiving influenza vaccination, which should be considered as target groups for interventions to improve their influenza vaccination uptake 36 : 1) residents in large urban areas; 2) men 65-69 years old; 3) women ≥70 years old; 4) smokers; 5) women with few physician contacts; and 6) 65-69-year-olds with no chronic disease.
